Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)
about
Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus FungiIn vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.Multilocus variable-number tandem-repeat analysis of clinical isolates of Aspergillus flavus from Iran reveals the first cases of Aspergillus minisclerotigenes associated with human infection.Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece.Aspergillus fumigatus and related species.Cryptic species and azole resistance in the Aspergillus niger complex.Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, JapanPharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic modelTriazole Susceptibilities in Thermotolerant Fungal Isolates from Outdoor Air in the Seoul Capital Area in South Korea.Nationwide Surveillance of Azole Resistance in Aspergillus DiseasesEmergence of persistent Aspergillus terreus colonisation in a child with cystic fibrosisCryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.Identification by Molecular Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Profiles of Clinically Significant Rare Aspergillus Species in a Referral Chest Hospital in Delhi, IndResistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus sppCorrelation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.A case report of intravenous posaconazole in hepatic and renal impairment patient with invasive Aspergillus terreus infection: safety and role of therapeutic drug monitoringIn vitro pharmacokinetic/pharmacodynamic modeling of voriconazole activity against Aspergillus species in a new in vitro dynamic model.In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales OrderAntifungal Susceptibility Testing of Aspergillus spp. by Using a Composite Correlation Index (CCI)-Based Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method Appears To Not Offer Benefit over Traditional Broth MicrodilCryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.The Epidemiologic and Pharmacodynamic Cutoff Values of Tilmicosin against Haemophilus parasuisEpidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)Is azole resistance in Aspergillus fumigatus a problem in Spain?In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogrIn vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.Screening and Characterization of a Non-cyp51A Mutation in an Aspergillus fumigatus cox10 Strain Conferring Azole Resistance.Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.Invasive aspergillosis: resistance to antifungal drugs.Antifungal susceptibility testing: a primer for clinicians.Voriconazole in clinical practice.
P2860
Q28068091-C2D00FC9-E9B4-4978-A180-88B36AB977FBQ30902025-5347016A-F4F3-4028-8DEB-74B05D96A8C0Q30938136-69FC6061-F9DE-4C3F-8CA9-CFAEF8352FBBQ33583405-D4B8268F-9F75-4640-BC3A-6502FAC08A84Q33905034-019E850F-F620-40D0-A14F-560D97B61659Q34005900-34E500DA-74D9-445D-84C2-4A7D8A601109Q34532546-58818E49-0C25-4CA2-9764-D449275A3668Q34596993-94753131-3ADE-4AB0-981F-887BF4D7EF47Q34621506-E18D316B-B476-424D-B8F2-041A8879EF77Q34933141-31E4AED5-3993-4003-BD3B-440A326E268AQ35005122-83739F46-047A-4E11-A357-65B7B7C007E2Q35045054-9B0DB129-7A77-49E1-9782-A5496F490315Q35270458-BAB71F94-18BE-4DB7-BA4D-1C98C5549B15Q35666518-B565565C-9A87-4A13-ACC8-996541DAA3A1Q35666627-EBE0AD17-1996-4B5A-BF21-7890317F183AQ35787585-38CF7505-925C-407F-8E46-6E5F1739AD62Q35860149-07C1F4D6-A9C4-41D4-9D39-D698C94BC3BCQ35947593-9E27AF92-53F0-4256-97FD-9C6372B5A97DQ36018713-3AE245F5-9C6A-448C-A1F7-D28493780234Q36076937-09A9F039-4A3F-4D42-A743-768306CD47DCQ36118607-FF7D3A7D-FC23-461F-BA90-2ED90F026DA7Q36171554-4F8C591C-FA29-4FCB-8EE4-38C761868A92Q36172416-A10A57CD-AEE2-41E9-9D28-76AC8D33B990Q36265747-5045E323-1375-4AFE-8E0B-382C1288BF83Q36276895-3DF515B1-54CE-4020-B786-5EF309E2A117Q36290764-39C5FE51-5F31-4CCC-B0E2-EDC163F0E220Q36345309-3D689DB4-30E8-4A94-A2F0-685CE6D2F8B3Q36364064-9B29E002-C42C-4325-8A08-E8921AD6976FQ36713673-E10E798C-3A45-40BD-BA4F-E8210C0DA394Q36898053-80136E1C-9826-47DA-818E-D9BC1510AE23Q37026702-671520A1-AD89-481A-B28D-4A1991ED1B90Q37036173-1A7A42E0-4CD0-40B9-BC26-F4BE9ADED474Q37036246-5911DC81-C2CF-4295-9012-A5BCFD694257Q37497644-F631393E-6008-4BB7-9882-341BDC7F44C6Q37538667-9820684C-70A6-4C65-B9FA-BAC9BFE6AE2DQ37538782-AEA04EAF-1D34-48CE-BDBC-0112F535F1FFQ37669855-6FFDF043-FC98-44D5-A7FB-753D6503C503Q37983464-1BA4B283-567B-4F18-A98E-AA92323E9CACQ38061087-24D344FE-FE80-4BBE-892D-C7FBD20F4157Q38061736-A583D46C-1D1C-48B2-AFEA-C023F454ED35
P2860
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Wild-type MIC distributions an ...... ution method (M38-A2 document)
@en
Wild-type MIC distributions an ...... LSI broth microdilution method
@nl
type
label
Wild-type MIC distributions an ...... ution method (M38-A2 document)
@en
Wild-type MIC distributions an ...... LSI broth microdilution method
@nl
prefLabel
Wild-type MIC distributions an ...... ution method (M38-A2 document)
@en
Wild-type MIC distributions an ...... LSI broth microdilution method
@nl
P2093
P2860
P356
P1476
Wild-type MIC distributions an ...... ution method (M38-A2 document)
@en
P2093
A Espinel-Ingroff
A Fothergill
J Turnidge
M A Pfaller
M G Rinaldi
P2860
P304
P356
10.1128/JCM.00536-10
P407
P577
2010-06-30T00:00:00Z